Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jun 7;16(1):292.
doi: 10.1186/s13287-025-04372-9.

Hair growth stimulated by allogenic adipose-derived stem cells supplemented with ATP in a mouse model of dihydrotestosterone-induced androgenetic alopecia

Affiliations

Hair growth stimulated by allogenic adipose-derived stem cells supplemented with ATP in a mouse model of dihydrotestosterone-induced androgenetic alopecia

E López Bran et al. Stem Cell Res Ther. .

Abstract

Background: Androgenetic alopecia (AGA), also known as male or female pattern hair loss, is the most prevalent form of alopecia worldwide. Current treatments are based on hormone drugs, topical vasodilators and hair transplants. Newer options include stem cell therapy targeted at recovering the capacity for hair follicle regeneration. This study examines the effects of intradermally administering allogenic adipose-derived stem cells (ASCs) per se or supplemented with ATP in a mouse model of dihydrotestosterone (DHT)-induced AGA.

Methods: Male and female C57BL6-strain mice were treated with DHT to induce AGA and then given injections of treatment solution in a defined area of the depilated back skin, and the same injections three days later. The treatments tested were several concentrations of ASCs combined with two ATP formulations. Photographs of the treated zones were taken on days 7, 10, 14, 17 and 21 and subjected to Image J analysis. On day 21, skin samples were also obtained for histological analysis. The main outcome measure was percentage treated surface area showing hair regrowth on treatment days 17 and 21 expressed as five categories: null, poor, moderate, intense and complete (20, 40, 60, 80 and 100% respectively).

Results: The experimental groups found to show the highest number of male individuals with intense/complete hair regrowth on day 21 were those in which mice received low dose ASCs (1 ∙ 106) combined either with liposomal ATP or non-liposomal ATP. Both these groups showed significant differences compared to controls. In females, while low dose ASC treatments and the high dose ASC + liposomal ATP treatment led to no hair regrowth improvement over the control treatment, medium dose ASC (2 × 106) + non-liposomal ATP gave rise to greater regrowth scores.

Conclusions: Hair regrowth was improved in all experimental groups in which male mice were administered stem cell solutions supplemented with ATP. In female mice, the highest hair regrowth scores were observed for the medium dose ASC + liposomal ATP treatment.

Keywords: ATP; Adipose derived stem cells; Androgenetic alopecia; Hair growth; Mouse model.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics approval and consent to participate: The project “Terapia celular en el tratamiento de la alopecia androgenética inducida en ratón mediante el uso de células madre mesenquimales expandidas derivadas de tejido adipose ES280790000088” was approved by the Experimental Animal Ethical Committee of the Hospital Clínico San Carlos of Madrid (Jul 16, 2020) and the General Administration of Agriculture and Livestock of the Community of Madrid (Nov 18, 2021). Consent for publication: Not applicable. Competing interests: LPP, PTE and MLGM state no conflict of interest. ELB is an adviser for MMC INTERNATIONAL HEALTH HOLDING.

Figures

Fig. 1
Fig. 1
AGA model groups
Fig. 2
Fig. 2
Experimental treatment groups
Fig. 3
Fig. 3
Immunophenotype of 2x106 ASCs incubated in HTS + liposomal ATP solution. Through flow cytometry, the immunophenotype of the stem cells was assessed according to several markers (CD90; CD73; CD166; CD105 and CD44) 24 h after incubation of the ASCs with ATP [100 μM] in refrigerated conditions. Representative image
Fig. 4
Fig. 4
Male AGA model assessment. Hair regrowth photographs taken on days 0, 4, 7, 11, 14, 18 and 21 after depilation in male C57BL6 mice
Fig. 5
Fig. 5
Female AGA model assessment. Hair regrowth on days 0, 4, 7, 14 and 21 recorded in female C57BL6 mice after depilation
Fig. 6
Fig. 6
Male mice experimental groups. a Pictures of hair regrowth taken on day 17. b Visual classification into 5  levels of hair regrowth on day 17. c Pictures of hair regrowth taken on day 21. d Visual classification into 5 levels of hair regrowth on day 21 (AGA model groups included)
Fig. 6
Fig. 6
Male mice experimental groups. a Pictures of hair regrowth taken on day 17. b Visual classification into 5  levels of hair regrowth on day 17. c Pictures of hair regrowth taken on day 21. d Visual classification into 5 levels of hair regrowth on day 21 (AGA model groups included)
Fig. 7
Fig. 7
Female mice experimental groups. a Pictures of hair regrowth taken on day 17. b Visual classification into 5 levels of hair regrowth on day 17. c Pictures of hair regrowth taken on day 21. d Visual classification into 5 levels of hair regrowth on day 21 (AGA model groups included)
Fig. 7
Fig. 7
Female mice experimental groups. a Pictures of hair regrowth taken on day 17. b Visual classification into 5 levels of hair regrowth on day 17. c Pictures of hair regrowth taken on day 21. d Visual classification into 5 levels of hair regrowth on day 21 (AGA model groups included)
Fig. 8
Fig. 8
Box-and-whisker plots of modal grey values on day 7 (a) and day 10 (b) recorded in the experimental treatment groups of female and male mice
Fig. 9
Fig. 9
Box-and-whisker plots of raw integrated density on days 14 (a), 17 (b) and 21 (c) recorded in the experimental treatment groups of female and male mice
Fig. 9
Fig. 9
Box-and-whisker plots of raw integrated density on days 14 (a), 17 (b) and 21 (c) recorded in the experimental treatment groups of female and male mice
Fig. 10
Fig. 10
Box-and-whisker plots of hair growth rates on days 14 (a), 17 (b) and 21 (c) recorded in the experimental groups of male and female mice
Fig. 10
Fig. 10
Box-and-whisker plots of hair growth rates on days 14 (a), 17 (b) and 21 (c) recorded in the experimental groups of male and female mice
Fig. 11
Fig. 11
Representative images of histological findings in the skin of male mice in the control (a) and experimental (b) treatment groups. The experimental group showed greater hair follicle density and bulb diameter
Fig. 12
Fig. 12
Representative images of histological findings in the skin of female mice in the control (a) and experimental (b) treatment groups. The experimental group showed a higher hair follicle density

References

    1. Devjani S, Ezemma O, Kelley KJ, Stratton E, Senna M. Androgenetic alopecia: therapy update. Drugs. 2023;83(8):701. - PMC - PubMed
    1. Lee SW, Juhasz M, Mobasher P, Ekelem C, et al. A systematic review of topical finasteride in the treatment of androgenetic alopecia in men and women. J Drugs Dermatol. 2018;17(4):457–63. - PMC - PubMed
    1. Owczarczyk-Saczonek A, Krajewska-Włodarczyk M, Kruszewska A, Banasiak Ł, Placek W, Maksymowicz W, et al. Therapeutic potential of stem cells in follicle regeneration. Stem Cells Int. 2018;2018:1–16. - PMC - PubMed
    1. Hinnant T, Lechler T. Hair follicle stem cells feel the pressure. Cell Stem Cell. 2022;29(1):1–2. - PubMed
    1. Xie Y, Chen D, Jiang K, Song L, Qian N, Du Y, et al. Hair shaft miniaturization causes stem cell depletion through mechanosensory signals mediated by a Piezo1-calcium-TNF-α axis. Cell Stem Cell. 2022;29(1):70-85.e6. - PubMed

LinkOut - more resources